We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tissue Regenix Group Plc | LSE:TRX | London | Ordinary Share | GB00BNTXR104 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 68.50 | 12,983 | 07:31:26 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 67.00 | 70.00 | 68.50 | 68.50 | 68.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | USD 29.49M | USD -302k | USD -0.0043 | -159.30 | 48.34M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 15:57:03 | O | 4 | 67.81 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 18/7/2024 | 15:52 | UK RNS | Tissue Regenix Group PLC Grant of share options |
| 16/7/2024 | 11:30 | ALNC |  IN BRIEF: Tissue Regenix eyes revenue and adjusted profit growth |
| 16/7/2024 | 07:00 | UK RNS | Tissue Regenix Group PLC Half-Year Trading Update |
| 03/7/2024 | 13:16 | UK RNS | Tissue Regenix Group PLC Holding(s) in Company |
| 24/6/2024 | 16:12 | UK RNS | Tissue Regenix Group PLC Holding(s) in Company |
| 18/6/2024 | 17:15 | UK RNS | Tissue Regenix Group PLC Exercise of Options, Director Dealing and TVR |
| 14/6/2024 | 14:36 | ALNC | Tissue Regenix purchases Texas facility to generate cost savings |
| 14/6/2024 | 07:00 | UK RNS | Tissue Regenix Group PLC Building purchase |
| 25/4/2024 | 14:27 | UK RNS | Tissue Regenix Group PLC Result of AGM |
| 05/4/2024 | 15:52 | UK RNS | Tissue Regenix Group PLC Holding(s) in Company |
Tissue Regenix (TRX) Share Charts1 Year Tissue Regenix Chart |
|
1 Month Tissue Regenix Chart |
Intraday Tissue Regenix Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 24/7/2024 | 11:00 | Tissue Regenix delivering practical solutions to real clinical issues | 7,832 |
| 27/9/2021 | 18:42 | Tissue Regenix takes pole position in regeneration game | 2 |
| 26/5/2020 | 13:31 | Torex with Charts & News | 14 |
| 15/1/2020 | 07:09 | TOREX 2007 - THE TILLS RING AT LAST | 13 |
| 14/1/2020 | 20:51 | Terrane Minerals- Cu explorer, trading in Canada | 17 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-07-26 14:57:04 | 67.81 | 4 | 2.71 | O |
| 2024-07-26 14:18:04 | 67.00 | 300 | 201.00 | O |
| 2024-07-26 10:41:09 | 68.20 | 12,000 | 8,183.78 | O |
| 2024-07-26 09:50:02 | 67.90 | 679 | 461.04 | O |
| Top Posts |
|---|
Posted at 26/7/2024 09:20 by Tissue Regenix Daily Update Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 68.50p.Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £48,343,511. Tissue Regenix has a price to earnings ratio (PE ratio) of -159.30. This morning TRX shares opened at 68.50p |
Posted at 23/7/2024 14:25 by p1nkfish They are doing the right things.The share registry looks good - sensible holders with a track record. The ingredient left to add is time, can't force it. |
Posted at 23/7/2024 12:20 by emeraldzebra I always get frustrated when good results are announced only to be greeted with selling which often appears to be mindless and regardless of price. Must learn not to let it get to me. lol. |
Posted at 20/7/2024 13:01 by p1nkfish Only 3/4 through July and the monthly volume (2M) has been the highest since March 2023. July 2024 is an up month. March 2023 was a down month (possibly for tax loss selling).Last time there was a price up month of > 2M was January 2023 at about 3.07M. A counter trend move. We need a close above 73.3p to show price pressures have changed and if that happens at a volume of > 3M it will be a good sign as more of a longer term uptrend bias will be signalled. The 500K at 69p is interesting, let's hope for more and then a move upwards once the buyer is filled. My own opinion, may be totally wrong. Dyor etc. |
Posted at 13/7/2024 22:27 by pj84 simplicius I am not a chartist, but to chartists, the head and shoulders pattern signifies when a share has reached it's peak and the second shoulder confirms the start of a new downtrend (a bit like driving by looking in the rear view mirror to see what is coming next!) the inverse is just the opposite indicating the share has reached a bottom with the second shoulder confirming the start of a new uptrend.As with most things related to charts it often depends when you decide to choose the start of the trend and bamboo2 appears to be using the Feb high as the start of the inverse head and shoulders pattern but equally if you start it from a year or more ago you could say it is just continuing an uptrend with random movements in prices up and down in between. Fortunately in this case whilst not a chartist I also hope the share price trend will continue upwards. |
Posted at 03/7/2024 16:45 by cliffpeat 15.1% now held by Richard Sneller/Inthallo"We invest in organisations capable of large-scale change." 12.2% after adding in June, held by Lombard Odier Asset Management (Europe) Limited 15.04% Harwood Capital (London)at 30 April 2024 9.71% Mr Richard Griffiths (UK) at 30 April 2024 9.25% IP Group (London) at 30 April 2024 So 61+% in hands of 5 shareholders seems to me to make an approach by a predator fairly easy. Interims to 30 June were announced in September last year. T/o 2023 was £29.49m - still a tiny company but with production capacity for substantial growth. I would guess that a bid would have to be >£1 per share to be of any interest to these shareholders. However the directors' shareholdings appear to be very small though growing - so perhaps a few years away from a takeover. |
Posted at 03/7/2024 16:15 by bamboo2 IUG, also from the IPGroup stable, is in a very similar situation to TRX, as is also forecast to move to profit this year, but is not so fortunate in having share holders accumulating. It also derives much of its profit and growth from the US. |
Posted at 14/6/2024 22:47 by pj84 Todays announcement of the exercise of the option to purchase the building they were leasing looks positive for the company, particularly, as the mortgage payments are similar to the lease payments and they will now avoid any lease rental increases that were built into the lease agreement and they believe the pre agreed purchase price is also below the current fair market value of the building. |
Posted at 10/4/2024 22:19 by pj84 One of the main drawbacks of investing in early stage biotech companies is the need to keep raising funds but the report indicates the current cash should be sufficient. |
Posted at 20/3/2024 15:32 by mickhay3 https://youtu.be/c98 |
Posted at 11/8/2022 11:11 by livewireplus :-)) unfortunately no refunds ... but had some good times ... have ended-up married - but as wife earns more than me then can't complain .... pass the Tissue from the left-hand side. An interesting week so far for the TRX share price .... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
